May 22, 2019
Mayne Pharma cleared Sorilux for treating plaque psoriasis in the States
Mayne Pharma Group Limited got approval from the USFDA for Sorilux foam, 0.005% in adolescents, for treating plaque psoriasis of the scalp and body in patients 12 years and older.